TrialBMC anesthesiology2024

The 90% effective dose (ED90) of remimazolam for inhibiting responses to the insertion of a duodenoscope during ERCP.

Yan Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.